INS and type 2 diabetes mellitus: Given the progressive nature of T2DM,6 it is often necessary to advance therapy with injectable glucose lowering agents, either basal insulin (BI) or GLP‐1RA, or in combination whenever previous therapy has failed to bring HbA1c level to target.7